Neogen Q4 2024 Adj. EPS $0.10 Misses $0.12 Estimate, Sales $236.794M Beat $225.837M Estimate
Portfolio Pulse from Benzinga Newsdesk
Neogen Corporation reported its Q4 2024 financial results, with adjusted EPS of $0.10 missing the $0.12 estimate, but sales of $236.794 million beating the $225.837 million estimate.
July 30, 2024 | 11:01 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Neogen Corporation's Q4 2024 adjusted EPS of $0.10 missed the $0.12 estimate, but sales of $236.794 million beat the $225.837 million estimate. This mixed result may lead to short-term volatility in the stock price.
The mixed earnings report, with EPS missing estimates but sales beating expectations, is likely to create short-term volatility in Neogen's stock price. Investors may react negatively to the EPS miss but positively to the sales beat.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100